A platform for research: civil engineering, architecture and urbanism
A platform for research: civil engineering, architecture and urbanism
Analisis Efektivitas Biaya Terapi Pada Pasien Hipertensi Rawat Jalan
Hypertension is a non-communicable disease characterized by an increase in systolic and diastolic blood pressure for more than 140 mmHg and 90 mmHg. Besides, Pharmacoeconomic research is the process of identifying, measuring, and comparing the costs, risks and benefits of programs, services and therapies, as well as determining which alternative produces the best health outcome for the resources invested. It applied Cost-Effectiveness Analysis to determine the best therapeutic recommendation. This study aimed to identify the use of Amlodipine compared to Candesartan, therapy costs incurred by the patient, and the most cost-effective antihypertensive. In addition, this was descriptive and analytical research that was conducted retrospectively. The research subjects were 46 hypertensive patients using Amlodipine and Candesartan therapes who met the inclusion criteria. Then, the data were processed by applying ACER (average cost- effectiveness ratio) and ICER (incremental cost-effectiveness ratio). Finding Unveiled that hypertension is mainly suffered by females, namely 27 people with a percentage of 58.7%. in the age group of 51-60 years, females with hypertension as many as 14 people with a percentage of 51.9%. The effectiveness of Amlodipine therapy was 86.36% and Candesarta was 75%. At the same time, the ACER’s value showed that the most cost-effective was Candesartan with the value of ACER for IDR. 2.113, 58 per effectineness.
Analisis Efektivitas Biaya Terapi Pada Pasien Hipertensi Rawat Jalan
Hypertension is a non-communicable disease characterized by an increase in systolic and diastolic blood pressure for more than 140 mmHg and 90 mmHg. Besides, Pharmacoeconomic research is the process of identifying, measuring, and comparing the costs, risks and benefits of programs, services and therapies, as well as determining which alternative produces the best health outcome for the resources invested. It applied Cost-Effectiveness Analysis to determine the best therapeutic recommendation. This study aimed to identify the use of Amlodipine compared to Candesartan, therapy costs incurred by the patient, and the most cost-effective antihypertensive. In addition, this was descriptive and analytical research that was conducted retrospectively. The research subjects were 46 hypertensive patients using Amlodipine and Candesartan therapes who met the inclusion criteria. Then, the data were processed by applying ACER (average cost- effectiveness ratio) and ICER (incremental cost-effectiveness ratio). Finding Unveiled that hypertension is mainly suffered by females, namely 27 people with a percentage of 58.7%. in the age group of 51-60 years, females with hypertension as many as 14 people with a percentage of 51.9%. The effectiveness of Amlodipine therapy was 86.36% and Candesarta was 75%. At the same time, the ACER’s value showed that the most cost-effective was Candesartan with the value of ACER for IDR. 2.113, 58 per effectineness.
Analisis Efektivitas Biaya Terapi Pada Pasien Hipertensi Rawat Jalan
Madania, Madania (author) / Tuloli, Teti Sutriyati (author) / bangol, asnia asnia (author)
2021-10-29
doi:10.37311/ijpe.v1i3.11368
Indonesian Journal of Pharmaceutical Education; Vol 1, No 3 (2021): September-Desember 2021; 142-151 ; 2775-3670 ; 10.37311/ijpe.v1i3
Article (Journal)
Electronic Resource
English
DDC:
690
PENGARUH KOMERSIALISASI BIAYA RAWAT INAP PASIEN TERHADAP KINERJA RUMAH SAKIT
| DOAJ | 2009